Clinical Trial Update: A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART

View source ↗

Summary

This clinical trial update notes the completion of a pharmacoepidemiological study evaluating Symbicort SMART use in patients with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Bronchial Asthma | Status: COMPLETED